ジェネリック医薬品の製造・販売などの事業を営んでいると偽って社債購入を勧誘する「東洋堂製薬株式会社」に関する注意喚起

Since March 2016, consultations related to businesses that solicit the purchase of unsecured convertible bonds with stock acquisition rights under the false pretense that they are engaged in businesses such as the manufacture and sale of generic drugs have become commonplace among consumers in various regions. sent to the center.
Based on the provisions of Article 38, Paragraph 1 of the Consumer Safety Act (Act No. 50 of 2009), the Consumer Affairs Agency has issued a notice of unfair harm to the interests of consumers in transactions with Toyodo Pharmaceutical Co., Ltd. In order to prevent the occurrence or expansion of consumer damage, we will notify consumers.
For details, please see the Consumer Affairs Agency website.